Publication | Open Access
Radiological Versus Clinical <scp>1‐Year</scp> Outcomes of Dupilumab in Refractory <scp>CRSwNP</scp> : A <scp>Real‐Life</scp> Study
16
Citations
19
References
2023
Year
Level 4. According to the Oxford Center for Evidence-Based Medicine 2011 level of evidence guidelines, this non-randomized retrospective cohort study is classified as level 4 evidence Laryngoscope, 134:2626-2633, 2024.
| Year | Citations | |
|---|---|---|
Page 1
Page 1